News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Davis Todd C
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/27/2023 |
4
| Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 17,005 shares
@ $0
Granted 46,178 options to buy
@ $75.09, valued at
$3.5M
|
|
| 12/06/2022 |
4
| Davis Todd C (CEO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 132,000 options to buy
@ $69.7, valued at
$9.2M
|
|
| 08/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/22/2022 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Disposed of 252,207 shares
@ $0
Disposed/sold 22,685 restricted stock units
@ $0
Disposed/sold 48,123 options to buy
@ $2.93, valued at
$141k
Disposed/sold 85,760 options to buy
@ $3.66, valued at
$313.9k
|
|
| 02/01/2022 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 85,760 options to buy
@ $3.66, valued at
$313.9k
Granted 15,369 restricted stock units
@ $0
Exercised 7,684 restricted stock units
@ $0 |
|
| 12/23/2021 |
4
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Gifted 1,470 shares
@ $0 |
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Exercised 2,456 options to buy
@ $113.5, valued at
$278.8k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 831 shares
@ $0
Granted 2,468 options to buy
@ $117.58, valued at
$290.2k
|
|
| 06/09/2020 |
4
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Granted 65,700 options to buy
@ $2.39, valued at
$157k
|
|
| 04/30/2020 |
4
| Davis Todd C (Director) has filed a Form 4 on Vaxart, Inc.|
Txns:
| Sold 60,000 shares
@ $3.275, valued at
$196.5k
|
|
| 04/30/2020 |
3/A
| Davis Todd C (Director) has filed a Form 3/A on Vaxart, Inc. |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/01/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/15/2019 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 18,123 restricted stock units
@ $0 |
|
| 08/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2019 |
4
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 835 shares
@ $0
Granted 4,071 options to buy
@ $113.59, valued at
$462.4k
|
|
| 10/15/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/09/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/24/2018 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Converted 416,667 shares
@ $0
Converted 75 convertible preferred
@ $1.8, valued at
$135 |
|
| 08/17/2018 |
4
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 5,833 shares
@ $239.9289, valued at
$1.4M
Sold 3,167 shares
@ $239.5, valued at
$758.5k
|
|
| 08/16/2018 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Exercised 3,124 restricted stock units
@ $0 |
|
| 08/03/2018 |
4
| Davis Todd C (Director) has filed a Form 4 on BIODELIVERY SCIENCES INTERNATIONAL INC|
Txns:
| Granted 96,247 restricted stock units
@ $0
Granted 48,123 options to buy
@ $2.93, valued at
$141k
|
|
| 07/03/2018 |
4/A
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,474 options to buy
@ $0 |
|
| 06/21/2018 |
4
| Davis Todd C (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 493 shares
@ $0
Granted 2,474 options to buy
@ $76.77, valued at
$189.9k
|
|
|
|
|